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Low-energy nanoemulsions (LE-NEs) represent novel and multifunctional drug carriers [1]. 
Curcumin, a powerful pleiotropic molecule, was used as a model active ingredient in this 
study. However, due to physicochemical instability, poor solubility and low targeting efficacy, 
its potentials are still beyond the reach [2]. Therefore, the aim was to investigate developed 
LE-NEs as promising vehicles for curcumin delivery, linking microstructural properties of the 
carrier to delivery and biological performance. 
After structural investigation, applying several physicochemical techniques (photon 
correlation spectroscopy, differential scanning calorimetry, atomic force microscopy, electron 
paramagnetic resonance spectroscopy), efficacy of curcumin and curcumin-loaded LE-NEs was 
assessed in terms of antioxidant activity and in biological assays with several cell lines (Fem-
X, HeLa, MRC-5). 
All developed formulations had mean droplet diameter below 150nm, with narrow 
distribution. It was demonstrated that curcumin interacts with the interfacial region of the LE-
NE, being a part of the surfactant layer, closer to the lipophilic region. Scavenging activity of 
curcumin-loaded LE-NEs was high, remaining unaltered after several months of storage. 
Encapsulation in the LE-NE enhanced its safety profile, providing significant cytotoxicity 
towards HeLa and Fem-X compared to the effect towards MRC-5 (IC50=22.89±2.09; 
37.87±7.09 and 67.72±0.4µg/ml, respectively). After the cell cycle analysis, it was proved that 
the cycle arrest of the cancer cells mostly happened in the subG1 and G2/M phase, underlining 
the ability of curcumin to interact with numerous cellular signaling pathways. 
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